Kanakadi (utricaria) in childre
Phase 2
- Conditions
- Health Condition 1: L500- Allergic urticaria
- Registration Number
- CTRI/2019/06/019570
- Lead Sponsor
- Dr Rajeswari K
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Acute and chronic utricaria
Wheel formation
Itching
Erythymatous rashes.
Those who are willing to sign in consent form
Exclusion Criteria
Fever with rashes
Pitriasis rosea
Drug eruptions
Erythema multiforme
other systemic illness
Acute bronchospasm
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy of the trial drug is measured using utricaria activity scale and improvement in the clinical symptoms is assured.Timepoint: 1-48 days
- Secondary Outcome Measures
Name Time Method Improvement in the reduction of wheel formation,pruritis and prevention of recurrent utricarial rashes.Timepoint: 1-48 days